Epirubicin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Epirubicin Product Information
Epirubicin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Epirubicin. The product is supplied by Clearsynth under CAT No. CS-O-01481.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Epirubicin
CAS No.
56420-45-2
CAT No.
CS-O-01481
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C27H29NO11
Molecular Weight
543.53
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Epirubicin is supplied with detailed characterization data compliant with regulatory guideline. Epirubicin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Epirubicin.
Overview
"Epirubicin Base is a 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. T"
Synonyms
Epirubicin
Application Notes
"Epirubicin Base is a 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. T"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.